tiprankstipranks
Coherus Biosciences (CHRS)
:CHRS
US Market

Coherus Biosciences (CHRS) Income Statement

Compare
1,568 Followers

Coherus Biosciences Income Statement

Last quarter (Q4 2024), Coherus Biosciences's total revenue was $54.14M, a decrease of -40.84% from the same quarter last year. In Q4, Coherus Biosciences's net income was $-50.70M. See Coherus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 266.96M$ 257.24M$ 211.04M$ 326.55M$ 475.82M
Gross Profit
$ 149.41M$ 94.46M$ 140.96M$ 268.96M$ 438.16M
Operating Expenses
$ 261.07M$ 301.45M$ 397.84M$ 532.82M$ 281.84M
Depreciation and Amortization
$ 5.28M$ 3.79M$ 3.70M$ 5.66M$ 4.97M
EBITDA
$ 60.94M$ -193.94M$ -255.58M$ -260.69M$ 161.84M
Operating Income
$ -111.67M$ -203.20M$ -256.88M$ -263.86M$ 156.32M
Other Income/Expenses
$ 140.17M$ -35.07M$ -34.87M$ -23.24M$ -20.61M
Pretax Income
$ 28.51M$ -238.27M$ -291.75M$ -287.10M$ 135.71M
Net Income
$ 28.51M$ -237.89M$ -326.63M$ -306.32M$ 132.24M
Per Share Metrics
Basic EPS
$ 0.25$ -2.53$ -4.21$ -4.06$ 1.85
Diluted EPS
$ 0.25$ -2.53$ -4.21$ -4.06$ 1.62
Weighted Average Shares Outstanding
114.55M 94.16M 77.63M 75.45M 71.41M
Weighted Average Shares Outstanding (Diluted)
114.83M 94.16M 77.63M 75.45M 83.49M
Currency in USD

Coherus Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis